| Lactobacillus johnsonii N6.2 Mitigates the Development of Type 1 Diabetes in BB-DP Rats R Valladares, D Sankar, N Li, E Williams, KK Lai, AS Abdelgeliel, ... Plos one 5 (5), e10507, 2010 | 311 | 2010 |
| Lactobacillus johnsonii inhibits indoleamine 2,3‐dioxygenase and alters tryptophan metabolite levels in BioBreeding rats R Valladares, L Bojilova, AH Potts, E Cameron, C Gardner, G Lorca, ... The FASEB Journal 27 (4), 1711-1720, 2013 | 152 | 2013 |
| Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma K McCauley, J Durack, R Valladares, DW Fadrosh, DL Lin, A Calatroni, ... Journal of Allergy and Clinical Immunology 144 (5), 1187-1197, 2019 | 138 | 2019 |
| Lactobacillus johnsonii N6. 2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in … SDK Kingma, N Li, F Sun, RB Valladares, J Neu, GL Lorca The Journal of nutrition 141 (6), 1023-1028, 2011 | 96 | 2011 |
| Finding the right fit: evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data JL Gehrig, DM Portik, MD Driscoll, E Jackson, S Chakraborty, D Gratalo, ... Microbial Genomics 8 (3), 000794, 2022 | 44 | 2022 |
| Structural and enzymatic characterization of NanS (YjhS), a 9‐O‐Acetyl N‐acetylneuraminic acid esterase from Escherichia coli O157:H7 ES Rangarajan, KM Ruane, A Proteau, JD Schrag, R Valladares, ... Protein Science 20 (7), 1208-1219, 2011 | 43 | 2011 |
| Complete genome sequences of Lactobacillus johnsonii strain N6. 2 and Lactobacillus reuteri strain TD1 MT Leonard, RB Valladares, A Ardissone, CF Gonzalez, GL Lorca, ... Genome announcements 2 (3), 10.1128/genomea. 00397-14, 2014 | 23 | 2014 |
| H2O2 production rate in Lactobacillus johnsonii is modulated via the interplay of a heterodimeric flavin oxidoreductase with a soluble 28 Kd PAS domain … RB Valladares, C Graves, K Wright, CL Gardner, GL Lorca, CF Gonzalez Frontiers in Microbiology 6, 716, 2015 | 20 | 2015 |
| The structure of a putative S‐formylglutathione hydrolase from Agrobacterium tumefaciens KE van Straaten, CF Gonzalez, RB Valladares, X Xu, AV Savchenko, ... Protein Science 18 (10), 2196-2202, 2009 | 20 | 2009 |
| Microbial consortium and uses thereof S Lynch, N Kimes, D Lin, R Valladares, K Fujimura US Patent 10,668,118, 2020 | 13 | 2020 |
| Dual epithelial and immune cell function of Dvl1 regulates gut microbiota composition and intestinal homeostasis H Belinson, AK Savage, D Fadrosh, YM Kuo, D Lin, R Valladares, ... JCI insight 1 (10), 2016 | 13 | 2016 |
| National Institute of Allergy and Infectious Diseases–sponsored Inner-City Asthma Consortium. Distinct nasal airway bacterial microbiotas differentially relate to exacerbation … K McCauley, J Durack, R Valladares, DW Fadrosh, DL Lin, A Calatroni, ... J Allergy Clin Immunol 144 (5), 1187-1197, 2019 | 10 | 2019 |
| Identification and characterization of feruloyl esterases produced by probiotic bacteria KK Lai, C Vu, RB Valladares, AH Potts, CF Gonzalez Protein Purif, 151-166, 2012 | 5 | 2012 |
| Compositions for treating inflammation and uses thereof S Lynch, N Kimes, D Lin, R Valladares, K Fujimura US Patent 11,033,588, 2021 | 4 | 2021 |
| A live microbial biotherapeutic product for induction of allergy-protective immunity BM Fiebiger, RB Valladares, SV Lynch, NE Kimes Journal of Allergy and Clinical Immunology 143 (2), AB68, 2019 | 3 | 2019 |
| Microbial consortia N Kimes, R Valladares, B Fiebiger, SV Lynch US Patent 11,369,644, 2022 | 2 | 2022 |
| Finding the right fit: A comprehensive evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data JL Gehrig, DM Portik, MD Driscoll, E Jackson, S Chakraborty, D Gratalo, ... bioRxiv, 2021.08. 31.458285, 2021 | 2 | 2021 |
| The Escherichia coli yjfP Gene Encodes a Carboxylesterase Involved in Sugar Utilization during Diauxie N Johns, A Wrench, F Loto, R Valladares, G Lorca, CF Gonzalez Journal of Molecular Microbiology and Biotechnology 25 (6), 412-422, 2015 | 2 | 2015 |
| Therapeutic pharmaceutical compositions N Kimes, R Valladares, N Vajrala US Patent 11,406,675, 2022 | 1 | 2022 |
| Microbial consortium and uses thereof S Lynch, N Kimes, D Lin, R Valladares, K Fujimura US Patent App. 17/233,194, 2021 | 1 | 2021 |
Claudio GonzalezProfessor, Microbiology and Cell Science, IFAS, University of Florida在 ufl.edu 的电子邮件经过验证
